Heritage Cannabis Holdings Corp banner
H

Heritage Cannabis Holdings Corp
CNSX:CANN

Watchlist Manager
Heritage Cannabis Holdings Corp
CNSX:CANN
Watchlist
Price: 0.005 CAD Market Closed
Market Cap: CA$5.3m

P/OCF

11.3
Current
No historical data
Comparison unavailable

Price to Operating Cash Flow (P/OCF) ratio compares a company`s market value to the cash it generates from its core operations.

P/OCF
11.3
=
Market Cap
CA$5.3m
/
Operating Cash Flow
CA$467.6k

Price to Operating Cash Flow (P/OCF) ratio compares a company`s market value to the cash it generates from its core operations.

P/OCF
11.3
=
Market Cap
CA$5.3m
/
Operating Cash Flow
CA$467.6k

Valuation Scenarios

Heritage Cannabis Holdings Corp is trading above its 3-year average

If P/OCF returns to its 3-Year Average (11.3), the stock would be worth CA$0.01 (0% downside from current price).

Statistics
Positive Scenarios
0/4
Maximum Downside
-9%
Maximum Upside
No Upside Scenarios
Average Downside
3%
Scenario P/OCF Value Implied Price Upside/Downside
Current Multiple 11.3 CA$0.01
0%
3-Year Average 11.3 CA$0.01
0%
5-Year Average 11.3 CA$0.01
0%
Industry Average 10.4 CA$0
-9%
Country Average 10.9 CA$0
-3%

Forward P/OCF
Today’s price vs future operating cash flow

Not enough data available to calculate forward P/OCF

Peer Comparison

All Multiples
P/OCF
P/E
All Countries
Close
Market Cap P/OCF P/E
CA
Heritage Cannabis Holdings Corp
CNSX:CANN
5.3m CAD 11.3 -0.3
US
Eli Lilly and Co
NYSE:LLY
820.3B USD 48.8 39.7
US
Johnson & Johnson
NYSE:JNJ
542.6B USD 22.1 25.8
CH
Roche Holding AG
SIX:ROG
248.4B CHF 13.7 20.1
UK
AstraZeneca PLC
LSE:AZN
216.7B GBP 19.5 27.8
CH
Novartis AG
SIX:NOVN
218.9B CHF 13.9 19.1
US
Merck & Co Inc
NYSE:MRK
272.8B USD 16.6 14.9
IE
Endo International PLC
LSE:0Y5F
244.4B USD 907.7 -83.6
DK
Novo Nordisk A/S
CSE:NOVO B
1.2T DKK 9.8 11.4
US
Pfizer Inc
NYSE:PFE
152.3B USD 13 19.6
US
Bristol-Myers Squibb Co
NYSE:BMY
116.3B USD 8.2 16.5
P/E Multiple
Earnings Growth PEG
CA
H
Heritage Cannabis Holdings Corp
CNSX:CANN
Average P/E: 21.7
Negative Multiple: -0.3
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
39.7
32%
1.2
US
Johnson & Johnson
NYSE:JNJ
25.8
8%
3.2
CH
Roche Holding AG
SIX:ROG
20.1
14%
1.4
UK
AstraZeneca PLC
LSE:AZN
27.8
25%
1.1
CH
Novartis AG
SIX:NOVN
19.1
14%
1.4
US
Merck & Co Inc
NYSE:MRK
14.9
14%
1.1
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -83.6 N/A N/A
DK
Novo Nordisk A/S
CSE:NOVO B
11.4
0%
N/A
US
Pfizer Inc
NYSE:PFE
19.6
22%
0.9
US
Bristol-Myers Squibb Co
NYSE:BMY
16.5
16%
1

Market Distribution

In line with most companies in Canada
Percentile
51st
Based on 1 917 companies
51st percentile
11.3
Low
0.1 — 7.2
Typical Range
7.2 — 17
High
17 —
Distribution Statistics
Canada
Min 0.1
30th Percentile 7.2
Median 10.9
70th Percentile 17
Max 26 053.9

Heritage Cannabis Holdings Corp
Glance View

Market Cap
5.3m CAD
Industry
Pharmaceuticals

Heritage Cannabis Holdings Corp. is a development stage company, which grows, sells, and distributes medical cannabis. The company is headquartered in Toronto, Ontario. The company went IPO on 2010-01-06. The firm focuses on extraction and the creation of extract and extract-derivative products and brands for adult use and cannabis-based medical solutions. The company has a portfolio of cannabis products under the brands Purefarma, Pura Vida, Really Awesome Dope (RAD), Premium 5, feelgood., ArthroCBD and CB4. In Canada, the Company operates through its wholly owned subsidiaries Voyage Cannabis Corp. (Voyage) and CannaCure Corporation (CannaCure). In the United States, the Company operates primarily through its wholly owned subsidiary, Opticann Inc. (Opticann), a Colorado-based oral and topical cannabinoid company, which has the rights to sell non-psychoactive cannabinoids Cannabidiol (CBD) and Cannabigerol (CBG), products made with the VESIsorb drug delivery system. The company operates two manufacturing facilities in Canada and offers products to both the medical and recreational legal cannabis markets.

CANN Intrinsic Value
Not Available
H
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett